Trasylol Lawyer
Bayer Stock dives on Trasylol news, but why?
- E-mail this Article
- Print this Article
- Text Size: A A
Editor: Jamie Sheller
Profession: Trasylol Attorney
Category: Trasylol News
On February , 2006 the FDA's warning on Bayer's Trasylol blood drug caused a small sell off. Within a few minutes, around 700,000 shares were traded. See article.
This is a little surprising, since a study was announced on this back in January with the findings showing the increased risk of this product compared to the generic equivalents. Maybe Bayer was able to "soften" that news until the FDA took action. I wonder when the insiders traded?
Trackback Pings
TrackBack URL for this entry:
http://myblog.clarislaw.com/usa/mt-tb.cgi/315